Collagenous colitis: Implications for the role of vascular endothelial growth factor in repair mechanisms

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 4, 2004, Pages 397-402

  Griga, Thomas ^a   Tromm, Andreas ^a   Schmiegel, Wolff ^a   Pfisterer, Okka ^a   Müller, Klaus M ^a   Brasch, Frank ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Collagenous colitis; Vascular endothelial growth factor; VEGF

Indexed keywords

BUDESONIDE; CD45 ANTIGEN; TENASCIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGENOUS COLITIS; COLON MUCOSA; CONTROLLED STUDY; DEGRADATION; DRUG EFFECT; EXTRACELLULAR MATRIX; FEMALE; FIBROGENESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; LAMINA PROPRIA; LONG TERM CARE; MALE; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ADMINISTRATION, ORAL; AGED; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD45; BUDESONIDE; COLITIS; COLLAGEN; COLON; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; TENASCIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1842505243     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200404000-00005     Document Type: Article

References (26)

1. Lee E, Schiller L, Vendrell D, Santa Ana CA, Fordtran JS. Subepithelial Collagen table thickness in colon specimens from patients with microscopic colitis and collagenous colitis. Gastroenterology 1992; 103:1790-1796.
2. Pardi D, Smyrk T, Tremaine W, Sandbom W. Microscopic colitis: a review. Am J Gastroenterol 2002; 97:794-802.
3. Bohr J, Olesan M, Tysk C, Jarnerot G. Collagenous and lymphocytic colitis: a clinical and histopathological review. Can J Gastroenterol 2000; 14:943-949.
4. Bohr J, Tysk C, Eriksson S, Abrahamsson H, Jarnerot G. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996; 39:846-851.
5. Zins B, Sandbom W, Tremaine W. Collagenous and lymphocytic colitis: subject review and therapeutic alternatives. Am J Gastroenterol 1995; 90:1394-1400.
6. Tromm A, Griga T, Möllmann H, May B, Muller KM, Fisseler-Eckhoff A. Budesonide for the treatment of collagenous colitis: first results of a pilot trial. Am J Gastroenterol 1999; 94:1871-1875.
7. Baert F, Schmit A, D'Haens G, Dedeurwaerdere F, Louis E, Cabooter M, et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002; 122:20-25.
8. Günther U, Schuppan D, Bauer M, Matthes H, Stallmach A, Schmitt-Graff A, et al. Fibrogenesis and fibrolysis in collagenous colitis: patterns of procollagen types I and IV, matrix-metalloproteinase-1 and -13, and TIMP-1 gene expression. Am J Pathol 1999; 155:493-503.
9. Müller S, Neureiter D, Stolte M, Verbeke C, Heuschmann P, Kirchner T, et al. Tenascin: a sensitive and specific diagnostic marker of minimal collagenous colitis. Virchows Arch 2001; 438:435-441.
10. End P, Panayotou G, Entwistle A, Waterfield MD, Chiquet M. Tenascin: a modulator of cell growth. Eur J Biochem 1992; 209:1041-1051.
11. Chiquet-Ehrismann R, Mackie E, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986; 47:131-139.
12. Aigner T, Neureiter D, Müller S, Kuspert G, Belke J, Kirchner T. Extracellular matrix composition and gene expression in collagenous colitis. Gastroenterology 1997; 113:136-143.
13. Dvorak H, Brown L, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular permeability and angiogenesis. Am J Pathol 1995; 146:1029-1039.
14. Brown L, Berse B, Jackman R, Tognazzi K, Manseau EJ, Senger DR, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993; 53:4727-4735.
15. Dvorak H, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR, et al. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995; 107:233-235.
16. Lee C, Kumar R, Lubowski D, Burcher E. Neuropeptides and nerve growth in inflammatory bowel disease. Dig Dis Sci 2002; 47:495-502.
17. Järnerot G, Tysk C, Bohr J, Eriksson S. Collagenous colitis and fecal stream diversion. Gastroenterology 1995; 109:449-455.
18. Hwang W, Kelly J, Shaffer E, Hershfield NB. Collagenous colitis: a disease of pericryptal fibroblast sheath? J Pathol 1986; 149:33-40.
19. Widgren S, Jlidi R, Cox J. Collagenous colitis: histologic, morphometric, immunohistochemical and ultrastructural studies. Report of 21 cases. Virchows Arch 1988; 413:287-296.
20. Unemori E, Ferrara N, Bauer E, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992; 153:557-562.
21. Lamoreaux W, Fitzgerald M, Reiner A, Hasty KA, Charles ST. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinase by microvascular endothelial cells in vitro. Microvasc Res 1998; 55:29-42.
22. Griga T, May B, Pfisterer O, Müller KM, Brasch F. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 2002; 49:116-123.
23. Anagnostopoulos I, Schuppan D, Riecken E, Gross UM, Stein H. Tehascin labelling in colorectal biopsies: a useful marker in the diagnosis of collagenous colitis. Histopathology 1999; 34:425-431.
24. Probstmeier R, Martini R, Schachner M. Expression of J1/tenascin in the crypt-villus unit of adult mouse small intestine: implications for its role in epithelial cell shedding. Development 1990; 109:313-321.
25. Ikuta T, Ariga H, Matsumoto K. Extracellular matrix tenascin in combination with vascular endothelial growth factor B enhances endothelial cell proliferation. Genes Cells 2000; 5:913-927.
26. Imai K, Kusakabe M, Sakakura T, Nakanishi I, Okada Y. Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases. FEBS 1994; 352:216-218.